Nuo Therapeutics, Inc. (AURX)

Equity Ratio

-58.46%

Quarterly · Period ending:

AURX logo

AURX Equity Ratio

Latest reported-58.46%
AURX Quarterly Equity Ratio (71.31% → -58.46%)
High-resolution chart · PNG

AURX equity ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. Equity Ratio — Quarterly
Period endingEquity Ratio
-58.4594%
-71.1253%
-51.8274%
-21.7679%
-60.6525%
-18.5805%
43.1869%
51.7937%
42.1348%
26.8297%
55.3362%
45.4229%
33.9885%
60.2488%
71.9094%
81.5216%
82.3939%
49.8225%
-348.5206%
-348.5206%
-336.9279%
-323.8122%
-3,337.5867%
-772.4501%
-154.2904%
-8.4046%
-76.5714%
-33.1807%
-18.9559%
33.9086%
82.9201%
78.162%
87.0217%
89.0068%
88.9315%
85.7703%
-599.4979%
-516.8097%
28.8882%
41.378%
38.6978%
28.3996%
20.3656%
23.9027%
49.8243%
56.888%
64.8784%
75.4544%
78.3798%
85.7268%
84.5444%
85.0704%
20.8993%
32.5603%
6.1313%
31.5235%
18.0268%
-0.8904%
14.3922%
31.9779%
35.8176%
59.6781%
70.2824%
52.2872%
61.3318%
65.5485%
82.1256%
80.3028%
84.4635%
86.0868%
82.9743%
82.9544%
83.8186%
83.3621%
86.1745%
85.6378%
80.4925%
81.0655%
82.3155%
80.1194%
77.7782%
79.8099%
83.1687%
84.5403%
78.7061%
77.6545%
80.9012%
75.3742%
76.6787%
75.7282%
65.5322%
34.3926%
-862.6536%
-808.6622%
-851.0132%
-384.135%
-5.2299%
26.0515%
56.1038%
67.5367%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.